Searched for
INDIAN PHARMA
Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...- Sensex jumps 299 points, Nifty closes near 23,450 as oil dips below $99/barrel. What can trigger the next sharp rally on D-Street?The Indian stock market closed positively on Wednesday, with Sensex climbing over 299 points to stand at 74,828, and Nifty gaining roughly ...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
- Economy’s swell, but reputation? Why India’s next growth story depends on how the world sees itIndia’s long-term economic prospects remain strong despite short-term geopolitical, currency and capital-flow challenges. As the country’s ...
- CAS chaos: Nifty’s indicative price drops 1% in seconds to fall below 23,150 on F&O expiry day, Sensex closes 330 pts lowerIndian equities ended lower on Tuesday after morning gains faded, with Sensex dropping 330 points and Nifty witnessing a sharp closing-auct...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- Why did market rise today? Sensex jumps 564 pts, Nifty closes above 23,400. 4 key factors driving the surgeIndian stock markets saw gains on Monday, with Sensex and Nifty rising. Cooling oil prices and strong global cues boosted investor sentimen...
- Chalet Hotels in advanced talks to buy Six Senses Vana for Rs 600 croreChalet Hotels is on the verge of acquiring Six Senses Vana in Dehradun, a luxurious wellness retreat owned by Veer Singh, son of Analjit Si...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- JioBlackRock CIO Rishi Kohli decodes Nifty’s inflection point after two years of weak returnsJioBlackRock CIO Rishi Kohli says largecap valuations have de-rated, while Indian banks have underperformed global peers, creating potentia...
- Behind the Modi-Xi border thaw, India's dependence on Chinese imports, especially rare earths, keeps deepeningIndia faces a significant trade deficit with China, importing substantially more goods than it exports. Chinese firms offer superior price ...
- CAS chaos continues: Sensex indicative price tumbles nearly 1,000 points in seconds, closes in red but Nifty ends above 23,300Indian stock markets showed divergence as Sensex closed lower and Nifty ended higher. Sharp swings occurred during the closing auction sess...
- Yatharth Hospitals shares rally 10% to fresh record high as Advent set to acquire 25% stake; stock up 20% in two daysYatharth Hospital shares surged over 10% after Advent International announced a Rs 3,150-crore investment for a 24.9% stake in the hospital...
- Market wrap: HDFC Life, Tata Motors PV, BEL, HDFC Bank, ONGC top gainers and losers on Nifty and Sensex on ThursdayIndian equities ended mixed on Thursday, with the Sensex declining marginally while the Nifty gained 0.23%. HDFC Life, Tata Motors PV and S...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Stocks in news: Yes Bank, Vedanta, Groww, BHEL, Bharat Forge and NBCCIndian equity markets closed lower on Tuesday, extending their monthly decline. Nifty50 reached a key support level, indicating a potential...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- US sanctions on Iran: Basmati demand stays strong, pharma and livestock exporters face new hurdlesIranian demand for Indian basmati remains resilient despite tougher US sanctions, but exporters are facing rising shipping, insurance, and ...
Load More
